Teleflex Incorporated (TFX:NYSE) closed at $123.58 on October 14, 2026, down 0.69% on the day. The stock trades 14.8% below its 52-week high of $145.00 and 23.4% above its 52-week low of $100.18. Over the past year, it gained 1.8%. Teleflex Incorporated is part of the Health Care sector (Medical/Dental Instruments).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -0.54% | -4.50% | -7.97% | -5.43% | +1.77% |
In 252 trading sessions since October 13, 2025, TFX closed higher on 118 days (47%). Its best day was April 22, 2026 (+11.27%) and its worst was January 8, 2026 (-13.06%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products consisting of Arrow branded catheters and related devices for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and withdrawal of blood samples; interventional access products that are used in dialysis, oncology, and critical care therapies; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. The company also provides surgical products, such as ligating clips and fascial closure systems; bladeless access ports, sutures, and other surgical instruments; and single-use and reusable products for surgical procedures under the Deknatel, Pilling, Kmedic, Hem-o-lok, and Weck brands. In addition, it offers medical devices for use in critical care, surgical, and cardiac care applications; and respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation...
Find more stocks like TFX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.